bioAffinity Technologies is a San Antonio, Texas-based biotechnology company focused on noninvasive tests for the detection of early-stage lung cancer ...
News
- bioAffinity Technologies closes $3.2M public offering - StreetInsider
- bioAffinity Technologies Announces Closing of $3.2 Million Offering - Las Vegas Sun News
... SAN ANTONIO, Texas--(BUSINESS WIRE)--Jun 18, 2026--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the ...
- bioAffinity Technologies Announces Closing of $3.2 Million Offering | The AI Journal
SAN ANTONIO, Texas--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company focused on the need for ...
- bioAffinity Technologies Announces Closing of $3.2 Million Offering
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jun 18, 2026--. bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on the ...
- Vice president for development, health affairs and health system named
Written by Jennilee Garza. The University of Texas at San Antonio has named Corey Pashea, MHS, as vice president for development, health affairs ...